| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |